Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats

British Journal of Nutrition

Volumn 107, Issue 1, 2012, Pages 86-95

  Conde, Silvia V ^a   Nunes Da Silva, Tiago ^a   Gonzalez, Constancio ^b,c,d   Mota Carmo, Miguel ^a   Monteiro, Emilia C ^a   Guarino, Maria P ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c Universidad de Valladolid and Consejo Superior de Investigaciones Científicas   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Caffeine; Catecholamines; Hypertension; Insulin resistance

Indexed keywords

ADRENALIN; CAFFEINE; CARVEDILOL; CATECHOLAMINE; DRINKING WATER; FATTY ACID; GLUTATHIONE; INSULIN; NITRIC OXIDE; NORADRENALIN; SUCROSE;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; FLUID INTAKE; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPID DIET; LIVER LEVEL; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROTECTION; RAT; SUGAR INTAKE; WEIGHT GAIN;

ADIPOSITY; ADRENERGIC ANTAGONISTS; ANIMALS; BODY WEIGHT; CAFFEINE; CARBAZOLES; CATECHOLAMINES; DIETARY FATS; DIETARY SUCROSE; FATTY ACIDS, NONESTERIFIED; FEMALE; HYPERGLYCEMIA; HYPERTENSION; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; PROPANOLAMINES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84855787744     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002406     Document Type: Article

References (62)

1. Kashyap SR & Defronzo RA (2007) The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 4, 13-19. (Pubitemid 46649069)
2. Riksen NP, Rongen GA & Smits P (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121, 185-191.
3. Moisey LL, Kacker S, Bickerton AC, et al. (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87, 1254-1261. (Pubitemid 351679766)
4. Keijzers GB, De Galan BE, Tack CJ, et al. (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364-369. (Pubitemid 41079637)
5. Van Dam RM, Willett WC, Manson JE, et al. (2006) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29, 398-403. (Pubitemid 44106525)
6. Van Dam RM & Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360, 1477-1478. (Pubitemid 35356327)
7. Noordzij M, Uiterwaal CS, Arends LR, et al. (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23, 921-928. (Pubitemid 40637906)
8. Jee SH, He J, Whelton PK, et al. (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33, 647-652. (Pubitemid 29091641)
9. Geleijnse JM (2008) Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag 4, 963-970.
10. Conde SV, Pinto P, Bárbara C, et al. (2009) Should caffeine be avoided in obstructive sleep apnea? In European Respiratory Society Annual Congress, Vienna, Austria: 2009. Abstracts book P3729.
11. Arnlov J, Vessby B & Riserus U (2004) Coffee consumption and insulin sensitivity. JAMA 291, 1199-1201.
12. Greenberg JA, Boozer CN & Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84, 682-693. (Pubitemid 44715648)
13. Zheng G, Sayama K, Okubo T, et al. (2004) Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 18, 55-62. (Pubitemid 38263372)
14. Lopez-Garcia E, van Dam RM, Rajpathak S, et al. (2006) Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83, 674-680. (Pubitemid 44699215)
15. Greenberg JA, Axen KV, Schnoll R, et al. (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29, 1121-1129. (Pubitemid 41192221)
16. Wu T, Willett WC, Hankinson SE, et al. (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28, 1390-1396. (Pubitemid 40756702)
17. Cheung WT, Lee CM & Ng TB (1988) Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology 36, 331-339.
18. Astrup A, Breum L, Toubro S, et al. (1992) The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 16, 269-277.
19. Sung BH, Whitsett TL, Lovallo WR, et al. (1994) Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men. Am J Hypertens 7, 755-758. (Pubitemid 24269764)
20. Sung BH, Lovallo WR, Whitsett T, et al. (1995) Caffeine elevates blood pressure response to exercise in mild hypertensive men. Am J Hypertens 8, 1184-1188.
21. Pincomb GA, Lovallo WR, McKey BS, et al. (1996) Acute blood pressure elevations with caffeine in men with borderline systemic hypertension. Am J Cardiol 77, 270-274. (Pubitemid 26059296)
22. Benowitz NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41, 277-288. (Pubitemid 20121734)
23. Fredholm BB, Battig K, Holmen J, et al. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51, 83-133. (Pubitemid 29113867)
24. Robertson D, Wade D, Workman R, et al. (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67, 1111-1117. (Pubitemid 11090551)
25. Myers MG (1988) Effects of caffeine on blood pressure. Arch Intern Med 148, 1189-1193.
26. Holtzman SG & Finn IB (1988) Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 29, 411-418. (Pubitemid 19258282)
27. Gasior M, Shoaib M, Yasar S, et al. (1999) Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288, 1053-1073. (Pubitemid 29254143)
28. Shearer J, Severson DL, Su L, et al. (2009) Partial A1 adeno-sine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo. J Pharmacol Exp Ther 328, 306-311.
29. Ribeiro RT, Lautt WW, Legare DJ, et al. (2005) Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 48, 976-983. (Pubitemid 40767992)
30. Gasior M, Jaszyna M, Munzar P, et al. (2002) Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psychopharmacology (Berl) 162, 385-395. (Pubitemid 35001901)
31. Rodriguez-Perez JC, Losada A, Anabitarte A, et al. (1997) Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. J Pharmacol Exp Ther 283, 336-344. (Pubitemid 27438979)
32. Monzillo LU & Hamdy O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61, 397-412. (Pubitemid 38140057)
33. Kim SP, Ellmerer M, Van Citters GW, et al. (2003) Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52, 2453-2460. (Pubitemid 37210532)
34. Ismail NA, El Denshary EE & Montague W (1977) Adenosine and the regulation of insulin secretion by isolated rat islets of Langerhans. Biochem J 164, 409-413. (Pubitemid 8105678)
35. Kanazawa M, Xue CY, Kageyama H, et al. (2003) Effects of a high-sucrose diet on body weight, plasma triglycerides, and stress tolerance. Nutr Rev 61, S27-S33. (Pubitemid 37259946)
36. Delarue J & Magnan C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10, 142-148. (Pubitemid 46220305)
37. Lewis GF, Carpentier A, Adeli K, et al. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23, 201-229. (Pubitemid 34299024)
38. Egawa T, Hamada T, Kameda N, et al. (2009) Caffeine acutely activates 50adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles. Metabolism 58, 1609-1617.
39. Raney MA & Turcotte LP (2008) Evidence for the involvement of CaMKII and AMPK in Ca2 +-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J Appl Physiol 104, 1366-1373.
40. Dhalla AK, Chisholm JW, Reaven GM, et al. (2009) A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 193, 271-295.
41. Espinal J, Challiss RA & Newsholme EA (1983) Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett 158, 103-106. (Pubitemid 13011919)
42. Han DH, Hansen PA, Nolte LA, et al. (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47, 1671-1675. (Pubitemid 28476239)
43. Vergauwen L, Hespel P & Richter EA (1994) Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93, 974-981. (Pubitemid 24087146)
44. Rusing D, Muller CE & Verspohl EJ (2006) The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol 58, 1639-1645. (Pubitemid 46051680)
45. Figler RA, Wang G, Srinivasan S, et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes 60, 669-679.
46. Umemura T, Ueda K, Nishioka K, et al. (2006) Effects of acute administration of caffeine on vascular function. Am J Cardiol 98, 1538-1541. (Pubitemid 44779487)
47. Scharf G, Prustomersky S & Huber WW (2001) Elevation of glutathione levels by coffee components and its potential mechanisms. Adv Exp Med Biol 500, 535-539. (Pubitemid 34107052)
48. Varma SD & Hegde KR (2010) Prevention of oxidative damage to lens by caffeine. J Ocul Pharmacol Ther 26, 73-77.
49. Mytilineou C, Kramer BC & Yabut JA (2002) Glutathione depletion and oxidative stress. Parkinsonism Relat Disord 8, 385-387. (Pubitemid 36151653)
50. Jackisch R, Fehr R & Hertting G (1985) Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology 24, 499-507. (Pubitemid 15016063)
51. Tseng CJ, Chan JY, Lo WC, et al. (2001) Modulation of catecholamine release by endogenous adenosine in the rat adrenal medulla. J Biomed Sci 8, 389-394. (Pubitemid 32830587)
52. Robertson D, Frolich JC, Carr RK, et al. (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298, 181-186. (Pubitemid 8272275)
53. Debrah K, Haigh R, Sherwin R, et al. (1995) Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 89, 475-480.
54. Carella AM, Antonucci G, Conte M, et al. (2010) Antihy-pertensive treatment with b-blockers in the metabolic syndrome: a review. Curr Diabetes Rev 6, 215-221.
55. Bhatt P, Makwana D, Santani D, et al. (2007) Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism-an experimental study. Can J Physiol Pharmacol 85, 514-520. (Pubitemid 47309797)
56. Kveiborg B, Christiansen B, Major-Petersen A, et al. (2006) Metabolic effects of b-adrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs 6, 209-217. (Pubitemid 44285130)
57. Corsetti G, Pasini E, Assanelli D, et al. (2007) Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles. Pharmacol Res 55, 96-103. (Pubitemid 46186034)
58. Ofluoglu E, Pasaoglu H & Pasaoglu A (2009) The effects of caffeine on l-arginine metabolism in the brain of rats. Neurochem Res 34, 395-399.
59. Guarino MP & Macedo MP (2006) Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 147, 959-965.
60. Guarino MP, Correia NC, Raposo J, et al. (2001) Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside. Proc West Pharmacol Soc 44, 25-26. (Pubitemid 34087701)
61. Shi D & Daly JW (1999) Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol 19, 719-732. (Pubitemid 29370376)
62. Stonehouse AH, Adachi M, Walcott EC, et al. (2003) Caffeine regulates neuronal expression of the dopamine 2 receptor gene. Mol Pharmacol 64, 1463-1473. (Pubitemid 37532236)